World Health Organization Issues Alert Over Critical Shortage of Obesity Injections
Under 10% of individuals that would benefit from weight-loss injections including Wegovy are able to get them, states the global health agency as it releases its inaugural guidance on the therapies.
Given over a billion people worldwide currently classified as obese, it is urging broader and more equitable availability to GLP-1 medication.
Per forecasts, over two billion could be living with obesity by 2030 if no action is taken.
"Our new guidelines recognises that excess weight is a long-term condition that can be treated with holistic and continuous support," remarked its chief Tedros Adhanom Ghebreyesus.
Significant expense, insufficient output, and distribution challenges are significant hurdles to widespread access to the injections that can assist patients in reducing substantial body mass, notes the organization.
Skinny Jab Shortage
Even in the present most optimistic scenario, the production of these medications would only suffice for about 100 million people – fewer than 10% of the global need, per the WHO.
The guideline calls on governments and firms to expand access, by approaches such as licensing agreements.
Exclusive production rights on semaglutide – the main ingredient of a leading brand – is scheduled to end in a number of countries in 2026.
How Weight-Loss Injections Work
The injections replicate a natural hormone to delay gastric emptying, curb appetite and enhance feelings of fullness so people consume fewer calories.
Patients commonly begin shedding pounds after several weeks of starting on the weekly injections.
Research points to patients may regain a significant portion after a year of halting the treatment, because their usual food cravings resume.
To be carrying excess weight increases your likelihood for contracting diseases, including diabetes, cardiovascular issues, stroke, and specific cancers.
Obesity concerns people in countries worldwide and was responsible for over three and a half million deaths worldwide in 2024, as per the WHO.
